BR112017003164A2 - composição farmacêutica contendo cineol, método para tratar um paciente que sofre de rinite, uso de uma composição farmacêutica contendo cineol, e aplicador para aplicação intranasal tópica - Google Patents
composição farmacêutica contendo cineol, método para tratar um paciente que sofre de rinite, uso de uma composição farmacêutica contendo cineol, e aplicador para aplicação intranasal tópicaInfo
- Publication number
- BR112017003164A2 BR112017003164A2 BR112017003164A BR112017003164A BR112017003164A2 BR 112017003164 A2 BR112017003164 A2 BR 112017003164A2 BR 112017003164 A BR112017003164 A BR 112017003164A BR 112017003164 A BR112017003164 A BR 112017003164A BR 112017003164 A2 BR112017003164 A2 BR 112017003164A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- cineol
- containing pharmaceutical
- rhinitis
- applicator
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
a presente invenção se refere a uma composição farmacêutica contendo cineol determinada para a aplicação tópica, em particular, nasal, preferivelmente intranasal, assim como ao seu uso e a um dispositivo de aplicação contendo essa composição farmacêutica.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102014012040 | 2014-08-18 | ||
DE102014012278 | 2014-08-22 | ||
DE102014013145 | 2014-09-10 | ||
DE102014013189 | 2014-09-11 | ||
DE102014116903.4A DE102014116903A1 (de) | 2014-08-18 | 2014-11-19 | Cineolhaltige Zusammensetzung für die nasale Applikation |
PCT/EP2015/064373 WO2016026600A1 (de) | 2014-08-18 | 2015-06-25 | Cineolhaltige zusammensetzung für die nasale applikation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112017003164A2 true BR112017003164A2 (pt) | 2017-11-28 |
Family
ID=54067266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017003164A BR112017003164A2 (pt) | 2014-08-18 | 2015-06-25 | composição farmacêutica contendo cineol, método para tratar um paciente que sofre de rinite, uso de uma composição farmacêutica contendo cineol, e aplicador para aplicação intranasal tópica |
Country Status (12)
Country | Link |
---|---|
US (1) | US20170273935A1 (pt) |
EP (2) | EP3300722B1 (pt) |
JP (1) | JP6469843B2 (pt) |
KR (1) | KR20170036058A (pt) |
BR (1) | BR112017003164A2 (pt) |
CL (1) | CL2017000394A1 (pt) |
DE (2) | DE102014116903A1 (pt) |
EA (1) | EA033510B1 (pt) |
ES (2) | ES2764506T3 (pt) |
MX (1) | MX2017002239A (pt) |
PL (1) | PL3182957T3 (pt) |
WO (1) | WO2016026600A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE202015104410U1 (de) * | 2015-07-06 | 2016-07-13 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung für die Behandlung von Rhinitis |
DE202015104761U1 (de) * | 2015-09-01 | 2016-09-02 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Cineolhaltige wässrige Zusammensetzung für die nasale Applikation |
DE202015106123U1 (de) * | 2015-10-23 | 2016-10-27 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Monoterpenhaltige Zusammensetzung zur Behandlung von Erkrankungen der Nase |
US20200246311A1 (en) * | 2017-08-10 | 2020-08-06 | Elixir Ilac Arastirma Ve Gelistirme A.S. | Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate |
EP3552601A1 (de) * | 2018-04-11 | 2019-10-16 | Karl Bodenschatz | Pharmazeutische zusammensetzung enthaltend dexpanthenol und polihexanid |
AT16516U1 (de) * | 2019-03-18 | 2019-11-15 | Ulrich Sekotill Mba | Nasenspray |
US20220080020A1 (en) * | 2020-08-22 | 2022-03-17 | Luc Montagnier | Compositions and methods for reducing the transmissivity of illnesses using an oral delivery system |
CN112220102B (zh) * | 2020-09-25 | 2022-12-09 | 山东华熙海御生物医药有限公司 | 一种含透明质酸和依克多因的电子烟液及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1811868A (en) * | 1928-08-21 | 1931-06-30 | Rheinische Kampfer Fabrik | Process for preparing 1,8-cineol |
GB1514469A (en) * | 1974-08-01 | 1978-06-14 | Beecham Group Ltd | Oral hygiene compositions |
HU203667B (en) * | 1986-12-11 | 1991-09-30 | Roussel Uclaf | Process for producing synergetic zootechnical compositions containing three components |
US5114979A (en) * | 1989-10-18 | 1992-05-19 | Schering Corporation | Fruity flavored nasal decongestant composition |
WO1995013810A1 (en) * | 1993-11-19 | 1995-05-26 | Schering-Plough Healthcare Products Incorporated | Nasal spray compositions containing oxymetazoline |
DE19549421C2 (de) | 1995-11-10 | 1999-11-18 | Klosterfrau Mcm Vetrieb Gmbh | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden |
DE19541919C2 (de) | 1995-11-10 | 1997-11-20 | Klosterfrau Mcm Vetrieb Gmbh | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden |
DE10107659B4 (de) * | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin |
JP2004196676A (ja) * | 2002-12-16 | 2004-07-15 | Rohto Pharmaceut Co Ltd | 点鼻剤 |
DE10356248A1 (de) | 2003-11-13 | 2005-06-23 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden |
DE102007040615A1 (de) * | 2007-08-27 | 2009-03-05 | Bitop Ag | Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen |
CN101292976B (zh) * | 2008-06-26 | 2010-07-28 | 贵州宏宇药业有限公司 | 一种含有1,8-桉叶素和艾纳香素的药物组合物及其用途 |
IT1391170B1 (it) * | 2008-08-07 | 2011-11-18 | D M G Italia S R L | Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale |
DE102012005452A1 (de) * | 2011-12-30 | 2013-07-04 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung für die nasale Applikation mit verbesserter Stabilität |
DE102013001151A1 (de) * | 2013-01-24 | 2014-07-24 | Merz Pharma Gmbh & Co. Kgaa | Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit |
-
2014
- 2014-11-19 DE DE102014116903.4A patent/DE102014116903A1/de active Pending
- 2014-11-19 DE DE202014105553.3U patent/DE202014105553U1/de active Active
-
2015
- 2015-06-25 EA EA201790410A patent/EA033510B1/ru not_active IP Right Cessation
- 2015-06-25 JP JP2017508570A patent/JP6469843B2/ja active Active
- 2015-06-25 EP EP17203038.9A patent/EP3300722B1/de active Active
- 2015-06-25 PL PL15733408T patent/PL3182957T3/pl unknown
- 2015-06-25 WO PCT/EP2015/064373 patent/WO2016026600A1/de active Application Filing
- 2015-06-25 US US15/504,151 patent/US20170273935A1/en not_active Abandoned
- 2015-06-25 ES ES15733408T patent/ES2764506T3/es active Active
- 2015-06-25 ES ES17203038T patent/ES2834985T3/es active Active
- 2015-06-25 MX MX2017002239A patent/MX2017002239A/es unknown
- 2015-06-25 EP EP15733408.7A patent/EP3182957B1/de active Active
- 2015-06-25 BR BR112017003164A patent/BR112017003164A2/pt not_active Application Discontinuation
- 2015-06-25 KR KR1020177005254A patent/KR20170036058A/ko not_active Application Discontinuation
-
2017
- 2017-02-16 CL CL2017000394A patent/CL2017000394A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP6469843B2 (ja) | 2019-02-13 |
EP3300722A1 (de) | 2018-04-04 |
ES2834985T3 (es) | 2021-06-21 |
DE102014116903A1 (de) | 2016-02-18 |
PL3182957T3 (pl) | 2020-05-18 |
EA201790410A1 (ru) | 2017-10-31 |
DE202014105553U1 (de) | 2015-08-20 |
EP3300722B1 (de) | 2020-09-16 |
US20170273935A1 (en) | 2017-09-28 |
KR20170036058A (ko) | 2017-03-31 |
EP3182957B1 (de) | 2019-10-16 |
JP2017525701A (ja) | 2017-09-07 |
EP3182957A1 (de) | 2017-06-28 |
ES2764506T3 (es) | 2020-06-03 |
EA033510B1 (ru) | 2019-10-31 |
WO2016026600A1 (de) | 2016-02-25 |
MX2017002239A (es) | 2017-05-09 |
CL2017000394A1 (es) | 2017-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017003164A2 (pt) | composição farmacêutica contendo cineol, método para tratar um paciente que sofre de rinite, uso de uma composição farmacêutica contendo cineol, e aplicador para aplicação intranasal tópica | |
CL2018000542A1 (es) | Nuevos derivados de fenoximetilo. | |
CL2015002855A1 (es) | Derivados de oxopiridina sustituida. | |
CL2018000596A1 (es) | Nuevos compuestos bicíclicos como inhibidores de la atx | |
BR112017009648A2 (pt) | composto, métodos para tratamento de doenças alérgicas ou outras condições inflamatórias ou prevenção de doença, de rinite alérgica ou asma, composição, e, uso de um composto. | |
CL2016003398A1 (es) | Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo. | |
CL2016001889A1 (es) | (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1. | |
CL2016001911A1 (es) | Compuesto heterocíclico fusionado | |
CL2015000543A1 (es) | Derivados de alcanediil y alcanediil-c17, de ácido oleanólico compuestos intermediarios, composición parmacéutica y métodos asociados. | |
BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
CL2015001442A1 (es) | Metodo para tratar enfermedades pulmonares que comprende el uso de compuestos derivados del acido obeticolico. | |
CL2015000177A1 (es) | Composición para el tratamiento de la hiperlipidemia que comprende un derivado de oxintomodulina | |
CL2016002157A1 (es) | Anticuerpos anti-cd38 para el tratamiento de leucemia linfoide aguda | |
CL2014001956A1 (es) | Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas. | |
BR112017007123A2 (pt) | derivados de tetrahidroisoquinolina | |
BR112016021282A8 (pt) | processos para a preparação de compostos antifúngicos e os referidos compostos | |
CL2015001772A1 (es) | Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma. | |
CL2015000976A1 (es) | Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados. | |
GT201400090A (es) | 2-tiopirimidinonas | |
MX2015009276A (es) | Donadores de nitroxilo con indice terapeutico mejorado. | |
BR112017004056A2 (pt) | composições e métodos para detecção da proteína smn em um indivíduo e tratamento de um indivíduo | |
CL2016000038A1 (es) | Piraxolo-piridinaminas sustituidas | |
DK3103453T3 (da) | Medicinsk sammensætning omfattende heterocyklisk diamino-carboxamidforbindelse som aktiv bestanddel | |
BR112017002852A2 (pt) | compostos de azetidiniloxifenilpirrolidina | |
BR112016028316A2 (pt) | composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |